AZ’s Farxiga Gets FDA Priority Review For Heart Failure

Moves Ahead of Rival SGLT2 Inhibitors

 
• By Kevin Grogan
Priority_Fast_Lane
FDA not keeping AstraZeneca waiting • Source: Shutterstock

More from Cardiovascular

More from Therapeutic Category